MedPath
TGA Approval

MESALAZINE RMB mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack (310314)

310314

MESALAZINE RMB mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack

Southern Cross Pharma Pty Ltd

September 2, 2021

Medicine

Medicine

Active

Registered

Active Ingredients

mesalazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.